CASI Pharmaceuticals Statistics Share Statistics CASI Pharmaceuticals has 15.49M
shares outstanding. The number of shares has increased by 15.61%
in one year.
Shares Outstanding 15.49M Shares Change (YoY) 15.61% Shares Change (QoQ) 15.61% Owned by Institutions (%) 17.71% Shares Floating 3.08M Failed to Deliver (FTD) Shares 5,061 FTD / Avg. Volume 0.41%
Short Selling Information The latest short interest is 278.23K, so 1.8% of the outstanding
shares have been sold short.
Short Interest 278.23K Short % of Shares Out 1.8% Short % of Float 2.34% Short Ratio (days to cover) 5.68
Valuation Ratios The PE ratio is -1.11 and the forward
PE ratio is -1.04.
CASI Pharmaceuticals's PEG ratio is
-0.04.
PE Ratio -1.11 Forward PE -1.04 PS Ratio 1.52 Forward PS 0.3 PB Ratio 23.45 P/FCF Ratio -1.47 PEG Ratio -0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for CASI Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.09,
with a Debt / Equity ratio of 11.96.
Current Ratio 1.09 Quick Ratio 0.94 Debt / Equity 11.96 Debt / EBITDA -0.64 Debt / FCF -0.75 Interest Coverage -45.49
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $122.48K Profits Per Employee $-168.49K Employee Count 233 Asset Turnover 0.53 Inventory Turnover 3.31
Taxes Income Tax 1.19M Effective Tax Rate -3.12%
Stock Price Statistics The stock price has increased by -78.2% in the
last 52 weeks. The beta is 0.72, so CASI Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.72 52-Week Price Change -78.2% 50-Day Moving Average 1.9 200-Day Moving Average 2.1 Relative Strength Index (RSI) 26.29 Average Volume (20 Days) 1,230,846
Income Statement In the last 12 months, CASI Pharmaceuticals had revenue of 28.54M
and earned -39.26M
in profits. Earnings per share was -2.56.
Revenue 28.54M Gross Profit 11.15M Operating Income -39.62M Net Income -39.26M EBITDA -34.87M EBIT -37.2M Earnings Per Share (EPS) -2.56
Full Income Statement Balance Sheet The company has 13.47M in cash and 22.14M in
debt, giving a net cash position of -8.67M.
Cash & Cash Equivalents 13.47M Total Debt 22.14M Net Cash -8.67M Retained Earnings -700.08M Total Assets 31.2M Working Capital -19.57M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -29.22M
and capital expenditures -240K, giving a free cash flow of -29.46M.
Operating Cash Flow -29.22M Capital Expenditures -240K Free Cash Flow -29.46M FCF Per Share -1.92
Full Cash Flow Statement Margins Gross margin is 39.06%, with operating and profit margins of -138.84% and -137.57%.
Gross Margin 39.06% Operating Margin -138.84% Pretax Margin -133.4% Profit Margin -137.57% EBITDA Margin -122.18% EBIT Margin -138.84% FCF Margin -103.25%
Dividends & Yields CASI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for CASI is $4,
which is 205.3% higher than the current price. The consensus rating is "Buy".
Price Target $4 Price Target Difference 205.3% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 2, 2022. It was a
backward
split with a ratio of 1:10.
Last Split Date Jun 2, 2022 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -36.08 Piotroski F-Score 3
